Company intelligence / Profile preview

DPhar

Rovereto, Trentino-Alto Adige, Italy

Ownership: Private
Development stage: Other

Overview

DPhar is an Italian contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and advanced intermediates. Based in Rovereto, the company operates a significant manufacturing site that was formerly part of the Novartis/Sandoz group before being integrated into the Olon Group. DPhar provides large-scale chemical synthesis services, leveraging high-volume fermentation and chemical transformation capabilities to support global pharmaceutical clients. The company is a key component of Olon's global manufacturing network, focusing on high-quality standards and regulatory compliance for the life sciences industry.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on DPhar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DPhar.

Explore the full profile